Skip to main content
icon for Органический рост выручки Thermo Fisher (TMO) во втором квартале (не по GAAP)?
Финансы·TMO

Органический рост выручки Thermo Fisher (TMO) во втором квартале (не по GAAP)?

icon for Органический рост выручки Thermo Fisher (TMO) во втором квартале (не по GAAP)?
Финансы·TMO

Органический рост выручки Thermo Fisher (TMO) во втором квартале (не по GAAP)?

июл. 23

июл. 23

Более 4% 40%

2%-4% 33%

0%-2% 10.9%

<-2% <1%

Polymarket

$22,711 Объем

Более 4% 40%

2%-4% 33%

0%-2% 10.9%

<-2% <1%

Polymarket

$22,711 Объем

<-2%

$647 Объем

1%

-2%-0%

$3,417 Объем

<1%

0%-2%

$6,069 Объем

8%

2%-4%

$4,846 Объем

33%

Более 4%

$7,733 Объем

55%

This market will resolve according to Thermo Fisher's organic revenue growth (year-over-year) for the upcoming second fiscal quarter, as reported in its official company earnings materials. The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered. If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket. If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to the lowest bracket. If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket. If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market. The resolution source for this market is the specified company's official earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used. Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.**Thermo Fisher's Q2 2026 organic revenue growth faces pressure from ongoing U.S. academic research funding reductions and sluggish life-sciences tools demand, following Q1's 1% organic result.** Management raised full-year 2026 guidance to a 3.5% midpoint after Q1, citing pharma and biopharma investments as offsets, yet analysts highlight limited end-market inflection and conservative consensus revenue estimates near $12 billion (roughly 8% reported growth). Recent reports note academic and government client weakness persisting into 2026, contributing to the market-implied emphasis on sub-2% outcomes ahead of the July 23 earnings release. Trader positioning reflects uncertainty around whether quarterly organic performance will align with the annual path or reflect continued softness in core segments.

This market will resolve according to Thermo Fisher's organic revenue growth (year-over-year) for the upcoming second fiscal quarter, as reported in its official company earnings materials.

The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered.

If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket.

If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to the lowest bracket.

If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket.

If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market.

The resolution source for this market is the specified company's official earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used.

Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.
Объем
$22,711
Дата окончания
23 июл. 2026 г.
Открытие рынка
Jul 8, 2026, 7:08 PM ET

Resolver

0x69c47De9D...
This market will resolve according to Thermo Fisher's organic revenue growth (year-over-year) for the upcoming second fiscal quarter, as reported in its official company earnings materials. The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered. If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket. If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to the lowest bracket. If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket. If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market. The resolution source for this market is the specified company's official earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used. Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.
This market will resolve according to Thermo Fisher's organic revenue growth (year-over-year) for the upcoming second fiscal quarter, as reported in its official company earnings materials. The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered. If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket. If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to the lowest bracket. If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket. If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market. The resolution source for this market is the specified company's official earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used. Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.**Thermo Fisher's Q2 2026 organic revenue growth faces pressure from ongoing U.S. academic research funding reductions and sluggish life-sciences tools demand, following Q1's 1% organic result.** Management raised full-year 2026 guidance to a 3.5% midpoint after Q1, citing pharma and biopharma investments as offsets, yet analysts highlight limited end-market inflection and conservative consensus revenue estimates near $12 billion (roughly 8% reported growth). Recent reports note academic and government client weakness persisting into 2026, contributing to the market-implied emphasis on sub-2% outcomes ahead of the July 23 earnings release. Trader positioning reflects uncertainty around whether quarterly organic performance will align with the annual path or reflect continued softness in core segments.

This market will resolve according to Thermo Fisher's organic revenue growth (year-over-year) for the upcoming second fiscal quarter, as reported in its official company earnings materials.

The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered.

If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket.

If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to the lowest bracket.

If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket.

If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market.

The resolution source for this market is the specified company's official earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used.

Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.
Объем
$22,711
Дата окончания
23 июл. 2026 г.
Открытие рынка
Jul 8, 2026, 7:08 PM ET

Resolver

0x69c47De9D...
This market will resolve according to Thermo Fisher's organic revenue growth (year-over-year) for the upcoming second fiscal quarter, as reported in its official company earnings materials. The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered. If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to the lowest bracket. If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to the lowest bracket. If the reported value falls exactly between two brackets, this market will resolve to the higher range bracket. If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market. The resolution source for this market is the specified company's official earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used. Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.

Связанные

icon for Кока-Кола (KO) органический рост выручки во 2 квартале (non-GAAP) 5%-6,5%?

Кока-Кола (KO) органический рост выручки во 2 квартале (non-GAAP) 5%-6,5%?

37%
Да
icon for Органический рост продаж Amphenol (APH) во 2 квартале 28%-32%?

Органический рост продаж Amphenol (APH) во 2 квартале 28%-32%?

41%
Да
icon for Рост количества показов рекламы Meta (META) во втором квартале среди Family of Apps составил 16%-19%?

Рост количества показов рекламы Meta (META) во втором квартале среди Family of Apps составил 16%-19%?

38%
Да

Не доверяй внешним ссылкам.

Часто задаваемые вопросы

«Органический рост выручки Thermo Fisher (TMO) во втором квартале (не по GAAP)?» — это рынок прогнозов на Polymarket с 5 возможными исходами, где трейдеры покупают и продают акции на основе своих прогнозов. Текущий лидирующий исход — «Более 4%» с 56%, за ним следует «2%-4%» с 33%. Цены отражают вероятности сообщества в реальном времени. Например, акция по цене 56¢ означает, что рынок коллективно оценивает вероятность этого исхода в 56%. Эти коэффициенты постоянно меняются. Акции правильного исхода можно обменять на $1 каждую при разрешении рынка.

На сегодняшний день «Органический рост выручки Thermo Fisher (TMO) во втором квартале (не по GAAP)?» сгенерировал общий объём торгов $22.7K с момента запуска рынка Jul 8, 2026. Такой уровень активности отражает высокую вовлечённость сообщества Polymarket и гарантирует, что текущие коэффициенты формируются широким кругом участников рынка. Ты можешь отслеживать движение цен в реальном времени и торговать любым исходом прямо на этой странице.

Чтобы торговать на «Органический рост выручки Thermo Fisher (TMO) во втором квартале (не по GAAP)?», просмотри 5 доступных исходов на этой странице. Каждый исход показывает текущую цену, представляющую подразумеваемую вероятность рынка. Чтобы занять позицию, выбери исход, который считаешь наиболее вероятным, выбери «Да» для торговли в его пользу или «Нет» для торговли против, введи сумму и нажми «Торговать». Если твой выбранный исход окажется верным, твои акции «Да» принесут $1 каждая. Если нет — $0. Ты также можешь продать акции до разрешения.

Текущий фаворит для «Органический рост выручки Thermo Fisher (TMO) во втором квартале (не по GAAP)?» — «Более 4%» с 56%, что означает, что рынок оценивает вероятность этого исхода в 56%. Следующий ближайший исход — «2%-4%» с 33%. Эти коэффициенты обновляются в реальном времени по мере покупки и продажи акций. Заходи чаще или добавь страницу в закладки.

Правила разрешения «Органический рост выручки Thermo Fisher (TMO) во втором квартале (не по GAAP)?» точно определяют, что должно произойти, чтобы каждый исход был объявлен победителем, включая официальные источники данных, используемые для определения результата. Ты можешь просмотреть полные критерии разрешения в разделе «Правила» на этой странице над комментариями. Мы рекомендуем внимательно прочитать правила перед торговлей, так как они определяют точные условия, особые случаи и источники.